These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 3908587

  • 1. Immuno-histological localization of tissue polypeptide antigen (TPA) in gynecological malignancies.
    Ikarashi T, Takeuchi S, Sudo N, Ueda M, Furuya M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2117-20. PubMed ID: 3908587
    [Abstract] [Full Text] [Related]

  • 2. [A study on tumor marker of tissue-polypeptide-antigen (TPA) in gynecologic malignancies].
    Nakajima H, Hirata T, Norisugi T, Furuno K, Ikehata N, Utsunomiya A, Kobayashi K, Negishi Y, Akiya K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1877-83. PubMed ID: 6094688
    [Abstract] [Full Text] [Related]

  • 3. [The clinical significance of tissue polypeptide antigen (TPA) in the patients with gynecologic tumor].
    Inoue M, Inoue Y, Hiramatsu K, Tanaka Y, Yamasaki M, Ueda G, Minagawa J, Ozaki M, Yanagida T, Nishino H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 May; 36(5):779-84. PubMed ID: 6736725
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical significances of tissue polypeptide antigen in patients with gynecological malignancies].
    Ueda M, Sudo N, Furuya M, Arakawa O, Ikarashi T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2361-8. PubMed ID: 3001201
    [Abstract] [Full Text] [Related]

  • 6. [Serum CA 125 and TPA determination in malignant neoplasms of the uterus].
    Gadducci A, Facchini V, Bartolini T, Fioretti P.
    Ann Ostet Ginecol Med Perinat; 1988 Nov; 109(3):151-5. PubMed ID: 3207319
    [No Abstract] [Full Text] [Related]

  • 7. An immunologic comparison between serous cystadenocarcinoma of the ovary and other human gynecologic tumors.
    Bhattacharya M, Barlow JJ.
    Am J Obstet Gynecol; 1973 Nov 15; 117(6):849-53. PubMed ID: 4126800
    [No Abstract] [Full Text] [Related]

  • 8. Clinical significance of different serum tumor markers in gynecological malignancies.
    Paulick R, Caffier H, Horner G, Lang K, Filbry E.
    Cancer Detect Prev; 1985 Nov 15; 8(1-2):115-20. PubMed ID: 4064031
    [Abstract] [Full Text] [Related]

  • 9. [Clinical usefulness of serum TPA, IAP and CEA levels in gynecological cancer].
    Saitoh S, Nakanishi A, Noda T, Ando Y, Kamamoto Y, Moriyama I, Ichijo M.
    Nihon Gan Chiryo Gakkai Shi; 1984 Aug 20; 19(7):1496-504. PubMed ID: 6520506
    [No Abstract] [Full Text] [Related]

  • 10. Serum levels of T.P.A. (tissue polypeptide antigen) in gynecological malignancies.
    Restaino A, Fanizza G, Battarino O.
    Eur J Gynaecol Oncol; 1986 Aug 20; 7(3):183-5. PubMed ID: 3780759
    [Abstract] [Full Text] [Related]

  • 11. Ca-125 levels in the conditioned media of the gynecological tumor cell lines.
    Ishiwata I, Ishiwata C.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan 20; 37(1):147-8. PubMed ID: 3855943
    [No Abstract] [Full Text] [Related]

  • 12. Lymphocyte function and HL-A antigen frequency in gynecologic squamous cancer. A preliminary report.
    Twomey PL, Rogentine GN, Chretien PB.
    Int Surg; 1974 Sep 20; 59(9):468-72. PubMed ID: 4414534
    [No Abstract] [Full Text] [Related]

  • 13. [Tissue polypeptide antigen in serum and tissue in patients with lung cancer].
    Haga E.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Apr 20; 28(4):595-604. PubMed ID: 2170727
    [Abstract] [Full Text] [Related]

  • 14. Carcinoembryonic antigen in malignant and nonmalignant gynecologic tumors: circulating levels and tissue localization.
    Rutanen EM, Lindgren J, Sipponen P, Stenman UP, Saksela E, Seppäla M.
    Cancer; 1978 Aug 20; 42(2):581-90. PubMed ID: 354771
    [No Abstract] [Full Text] [Related]

  • 15. [The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers].
    Suzumori K, Yasui Y, Asai H, Hisaoka T, Mizuno K, Yagami Y.
    Gan No Rinsho; 1985 May 20; 31(5):544-8. PubMed ID: 3860666
    [Abstract] [Full Text] [Related]

  • 16. [Tissue polypeptide antigen as a tumor marker for gynecologic malignancies].
    Inoue M, Fujita Y, Abe Y, Inoue Y, Ueda G, Tanizawa O, Minagawa J, Yamada T, Ohashi K, Ozaki M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep 20; 37(9):1799-805. PubMed ID: 4056529
    [Abstract] [Full Text] [Related]

  • 17. Relation between serum levels of tissue polypeptide antigen (TPA) and cancer antigen 125 (CA125) and their immunohistochemical identification in benign and malignant gynecological disease.
    Fukazawa I, Inaba N, Ota Y, Sato N, Shirotake S, Iwasawa H, Sato T, Takamizawa H, Wiklund B.
    Arch Gynecol Obstet; 1988 Sep 20; 243(1):41-50. PubMed ID: 3165614
    [Abstract] [Full Text] [Related]

  • 18. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM, Wang PH, Yen MS, Lai CR, Ng HT, Yuan CC.
    Gynecol Oncol; 2000 Jan 20; 76(1):103-6. PubMed ID: 10620449
    [Abstract] [Full Text] [Related]

  • 19. [Clinical study on tissue polypeptide antigen (TPA) in gastric cancer].
    Kanauchi M, Sawai F, Hirayama T, Yumura F, Kanauchi K, Hamaguchi T, Hara Y, Yoshimura K, Nishiura K, Dohi K.
    Gan No Rinsho; 1985 Sep 20; 31(11):1367-71. PubMed ID: 2999464
    [Abstract] [Full Text] [Related]

  • 20. [Immunohistochemical tissue localization of TA-4 and CEA in uterine carcinomas].
    Kimura A, Maruo T, Hoshina M, Mochizuki M.
    Nihon Gan Chiryo Gakkai Shi; 1987 Jul 20; 22(6):1159-68. PubMed ID: 3323375
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.